STOCK TITAN

Acreage Holding - ACRDF STOCK NEWS

Welcome to our dedicated page for Acreage Holding news (Ticker: ACRDF), a resource for investors and traders seeking the latest updates and insights on Acreage Holding stock.

Acreage Holdings, Inc. (ACRDF), founded in 2014, stands as a leading multi-state operator in the American cannabis industry. Formerly known as High Street Capital Partners, Acreage has established a diverse portfolio across 11 states, encompassing cultivation, processing, and dispensing operations. The company is dedicated to expanding its footprint and capabilities as legislation and regulations evolve, ensuring the provisioning of safe, dosable, and affordable cannabis products.

Acreage collaborates closely with regulators, physicians, and medical researchers to set new industry standards. The company's management team boasts a blend of veterans from the retail, food and beverage, legal, and financial disciplines, complemented by pioneers in cannabis cultivation.

Notable brands under Acreage include the award-winning The Botanist and Superflux, with products available nationwide. Recently, The Botanist Danbury Dispensary in Connecticut reported a 64% year-over-year sales growth, and the company achieved record wholesale sales in New Jersey, supported by infrastructure upgrades at its Egg Harbor Township facility.

Financially, Acreage reported consolidated revenue of $56.5 million for Q3 2023, with an adjusted EBITDA of $6.6 million. The company continues to focus on cost controls and operational efficiencies, reducing operating expenses by 37% year-over-year.

With recent launches like Superflux's limited-edition strains in New Jersey and The Botanist’s THC-infused gummies in New York, Acreage continues to innovate its product offerings. The company remains poised for growth, especially with the upcoming adult-use markets in New York and Ohio.

As a vertically integrated operator, Acreage's expansion initiatives include new dispensary openings, such as the upcoming Botanist Vernon in Connecticut, and enhancements in production capabilities, positioning Acreage as a competitive force in the cannabis market.

Rhea-AI Summary

Acreage Holdings has appointed Dennis Curran as Chief Operating Officer while announcing the resignation of James Doherty, effective April 30, 2022. Curran brings over 35 years of experience from GSK Consumer Healthcare and Procter & Gamble. The management change aims to strengthen Acreage's leadership as it positions itself for growth in the cannabis market. Curran is expected to leverage his background in consumer-focused businesses to contribute to the company's ongoing success and profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.62%
Tags
management
-
Rhea-AI Summary

Acreage Holdings, a prominent multi-state cannabis operator, announced its fourth quarter and full year 2021 financial results will be released on March 10, 2022, after market close. A subsequent conference call is scheduled for March 11, 2022, at 10:00 a.m. ET, to discuss the results. Acreage operates various cannabis brands, including The Botanist, and has focused on creating a seamless, consumer-friendly experience since its inception in 2011. Investors can access the conference call via webcast on their website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.6%
Tags
-
Rhea-AI Summary

Acreage Holdings, Inc. has launched its cannabis craft brand Superflux in Illinois, Ohio, and Massachusetts, now available at around 100 retailers within three months. Additionally, the flagship brand The Botanist has expanded its product lines, introducing innovative items like solventless rosin CBD gummies. The new product portfolio aims to unlock wholesale and retail revenue streams, optimizing growth potential. Acreage continues to focus on quality and diversity, enhancing its market presence through strategic product development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.54%
Tags
none
Rhea-AI Summary

Acreage Holdings, Inc. has secured a $150 million credit facility with AFC Gamma and Viridescent Realty Trust. Of this, $100 million is immediately available, with an additional $50 million contingent on achieving specific milestones. The funds will support expansion, repay existing debt, and enhance working capital. The interest rate is set at 9.75%, maturing on January 1, 2026. This financing is viewed positively by Acreage's CFO as a means to enhance their balance sheet and increase operational flexibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.05%
Tags
none
-
Rhea-AI Summary

Acreage Holdings reported financial results for Q3 2021, marking its third consecutive quarter of positive Adjusted EBITDA. Consolidated revenue reached $48.2 million, up 52% year-over-year and 9% sequentially. Gross margin increased to 49% from 43% in Q3 2020. The net loss attributable to Acreage improved to $12.3 million from $40.5 million in the same quarter last year. The company divested retail dispensaries in Oregon for $6.5 million and acquired operations in Ohio, enhancing its market position. Management emphasized a focus on profitability and shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.13%
Tags
none
-
Rhea-AI Summary

Acreage Holdings announced the completion of a significant expansion at its Egg Harbor Township, New Jersey cultivation facility. This expansion has increased the cultivation capacity output by fourfold, aiming to meet the rising demand at Acreage’s retail locations, particularly The Botanist, and to strengthen its position in the growing wholesale market. The company operates three dispensaries in New Jersey and is focused on scaling operations in anticipation of adult-use sales. CEO Peter Caldini emphasized the strategic importance of this expansion for future growth in New Jersey.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
none
Rhea-AI Summary

Acreage Holdings announced the retirement of Chief Operating Officer, Robert J. Daino, effective March 31, 2022. A national search for his successor has commenced. Daino has been pivotal in driving the company's strategic objectives, profitability, and growth in core markets. CEO Peter Caldini acknowledged Daino's strong leadership and contributions to the company's development as a publicly traded multi-state cannabis operator. Acreage is well-positioned for continued growth with its diverse range of cannabis products, including the award-winning The Botanist brand.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Acreage Holdings is set to report its third quarter 2021 financial results on November 10, 2021, after market close. The conference call for discussing these results will occur on November 11, 2021, at 10:00 a.m. ET. Acreage, a multi-state operator in the cannabis sector, offers a variety of cannabis products under several brands including The Botanist and Tweed. The company aims to provide a seamless, consumer-focused experience since its inception in 2011.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
-
Rhea-AI Summary

Acreage Holdings has successfully completed its acquisition of cultivation, processing, and retail operations in Ohio for approximately $7.1 million in cash, $7.1 million in notes, and 1.1 million shares of its subsidiary. This includes a 70,000 sq. ft. facility and five retail dispensaries under the The Botanist brand, significantly enhancing Acreage's operational and financial standing. With an estimated market share of 20% in Ohio, the acquisition is expected to support Acreage's strategic focus on profitability and growth across its core markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.51%
Tags
Rhea-AI Summary

Acreage Holdings has entered into a definitive asset purchase and services agreement with Chalice Brands Ltd. to sell its four Cannabliss retail dispensaries in Oregon for $6.5 million. The deal includes a $250,000 cash payment and a 10-month secured promissory note for $6.25 million. This sale is part of Acreage's strategy to divest operations that negatively impact its bottom line, allowing a focus on core markets. The transaction also includes a working capital surplus of $500,000 and aims to ensure the buyer maintains break-even operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none

FAQ

What is the current stock price of Acreage Holding (ACRDF)?

The current stock price of Acreage Holding (ACRDF) is $0.122 as of February 7, 2025.

What is the market cap of Acreage Holding (ACRDF)?

The market cap of Acreage Holding (ACRDF) is approximately 5.0M.

What is Acreage Holdings' core business?

Acreage Holdings operates cannabis cultivation, processing, and dispensary facilities across 11 states in the U.S.

When was Acreage Holdings founded?

Acreage Holdings was founded in 2014.

What recent achievements has Acreage Holdings reported?

Acreage reported a 64% sales growth at The Botanist Danbury Dispensary in Connecticut and record wholesale sales in New Jersey.

What are some of Acreage Holdings' key brands?

The company's notable brands include The Botanist and Superflux.

What was Acreage Holdings' consolidated revenue for Q3 2023?

The company's consolidated revenue for Q3 2023 was $56.5 million.

What new products has Acreage Holdings recently launched?

Acreage has recently launched Superflux's limited-edition strains in New Jersey and The Botanist’s THC-infused gummies in New York.

What initiatives is Acreage Holdings pursuing for expansion?

Acreage is expanding through new dispensary openings and enhancing production capabilities, such as the new Botanist Vernon in Connecticut.

How does Acreage Holdings collaborate within the industry?

Acreage works with regulators, physicians, and medical researchers to set new industry standards.

Who makes up Acreage Holdings' management team?

The management team includes veterans from retail, food and beverage, legal, and financial disciplines, as well as cannabis cultivation pioneers.

What future markets is Acreage Holdings preparing to enter?

Acreage is preparing for the adult-use markets in New York and Ohio.
Acreage Holding

OTC:ACRDF

ACRDF Rankings

ACRDF Stock Data

4.97M
29.38M
13.76%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
New York